224 related articles for article (PubMed ID: 17245830)
1. Remicade approved for children with Crohn's disease.
FDA Consum; 2006; 40(4):6. PubMed ID: 17245830
[No Abstract] [Full Text] [Related]
2. FDA approves Cimzia to treat Crohn's disease.
Lang L
Gastroenterology; 2008 Jun; 134(7):1819. PubMed ID: 18474249
[No Abstract] [Full Text] [Related]
3. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
Diamanti A; Papadatou B; Knafelz D; Gambarara M; Ferretti F; Castro M
Am J Gastroenterol; 2003 Dec; 98(12):2812-3. PubMed ID: 14687847
[No Abstract] [Full Text] [Related]
4. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
[TBL] [Abstract][Full Text] [Related]
5. [What can be expected from biological therapies for Crohn's disease?].
Lemann M
Gastroenterol Clin Biol; 2001 Nov; 25(11):945-7. PubMed ID: 11845043
[No Abstract] [Full Text] [Related]
6. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
Loftus EV
Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
[No Abstract] [Full Text] [Related]
7. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
Lichtenstein GR
Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959
[No Abstract] [Full Text] [Related]
8. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
9. Re: Fefferman et al.--"Recurrence" of chronic pancreatitis appearing on a patient with underlying Crohn's disease.
Triantafillidis JK; Cheracakis P
Am J Gastroenterol; 2002 Mar; 97(3):761-2. PubMed ID: 11922579
[No Abstract] [Full Text] [Related]
10. Toxicity of infliximab in the course of treatment of Crohn's disease.
Bratcher JM; Korelitz BI
Expert Opin Drug Saf; 2006 Jan; 5(1):9-16. PubMed ID: 16370952
[TBL] [Abstract][Full Text] [Related]
11. [Clinical images in gastroenterology. Crohn's disease treated with Remicade].
Villanueva-Sáenz E; Wiener Carrillo I; Bolaños-Badillo LE; Blanco-Lucio RM
Rev Gastroenterol Mex; 2007; 72(4):381. PubMed ID: 18595330
[No Abstract] [Full Text] [Related]
12. Timing infliximab therapy in pediatric Crohn's disease.
Kirschner BS; Huo D
Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
[No Abstract] [Full Text] [Related]
13. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
Tilg H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W;
Z Gastroenterol; 2004 Oct; 42(10):1256-63. PubMed ID: 15508068
[No Abstract] [Full Text] [Related]
14. Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease.
Puli SR; Benage DD
Am J Gastroenterol; 2003 Apr; 98(4):939-40. PubMed ID: 12738486
[No Abstract] [Full Text] [Related]
15. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.
Moss AC; Treister NS; Marsee DK; Cheifetz AS
Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307
[No Abstract] [Full Text] [Related]
16. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.
Hanauer SB
Am J Gastroenterol; 2005 Jul; 100(7):1438-9. PubMed ID: 15984961
[No Abstract] [Full Text] [Related]
17. Crohn's disease. Achieving optimum health status.
Plante ML
Adv Nurse Pract; 2004 May; 12(5):28-35; quiz 35-6. PubMed ID: 15150912
[No Abstract] [Full Text] [Related]
18. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
[TBL] [Abstract][Full Text] [Related]
19. Anti-Saccharomyces cerevisiae antibodies and response to infliximab in refractory Crohn's disease.
Schröder O; Naumann M; Stein J
Aliment Pharmacol Ther; 2004 Oct; 20(7):823-4. PubMed ID: 15379845
[No Abstract] [Full Text] [Related]
20. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
